These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34638944)

  • 1. Intranasal Administration of
    Wang Y; An EK; Kim SJ; You S; Jin JO
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of Immune Checkpoint Inhibitor-Mediated Anti-Cancer Immunity by Intranasal Treatment of
    Zhang W; Hwang J; Yadav D; An EK; Kwak M; Lee PC; Jin JO
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysaccharide from
    Park HB; Hwang J; Zhang W; Go S; Kim J; Choi I; You S; Jin JO
    Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33302530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer immunotherapy using a polysaccharide from
    Park HB; Lim SM; Hwang J; Zhang W; You S; Jin JO
    Oncoimmunology; 2020 Jun; 9(1):1772663. PubMed ID: 32923129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astragalus membranaceus polysaccharides potentiate the growth-inhibitory activity of immune checkpoint inhibitors against pulmonary metastatic melanoma in mice.
    Hwang J; Zhang W; Dhananjay Y; An EK; Kwak M; You S; Lee PC; Jin JO
    Int J Biol Macromol; 2021 Jul; 182():1292-1300. PubMed ID: 34000307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19-IL2 cures poorly immunogenic tumors when combined with radiotherapy.
    Olivo Pimentel V; Marcus D; van der Wiel AM; Lieuwes NG; Biemans R; Lieverse RI; Neri D; Theys J; Yaromina A; Dubois LJ; Lambin P
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33688020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity.
    Alteber Z; Azulay M; Cafri G; Vadai E; Tzehoval E; Eisenbach L
    Cancer Immunol Immunother; 2014 Apr; 63(4):369-80. PubMed ID: 24452202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Peripheral Blood Dendritic Cell and T Cell Activation by
    Zhang W; Hwang J; Park HB; Lim SM; Go S; Kim J; Choi I; You S; Jin JO
    Mar Drugs; 2020 Oct; 18(11):. PubMed ID: 33120897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cells.
    Shinagawa N; Yamazaki K; Tamura Y; Imai A; Kikuchi E; Yokouchi H; Hommura F; Oizumi S; Nishimura M
    Cancer Immunol Immunother; 2008 Feb; 57(2):165-74. PubMed ID: 17628800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rehmannia glutinosa polysaccharide functions as a mucosal adjuvant to induce dendritic cell activation in mediastinal lymph node.
    Kwak M; Yu K; Lee PC; Jin JO
    Int J Biol Macromol; 2018 Dec; 120(Pt B):1618-1623. PubMed ID: 30282011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous administration of MIP-1alpha with intra-tumor injection of P. acnes shows potent anti-tumor effect.
    Nakano A; Yoneyama H; Ueha S; Kitabatake M; Ishikawa S; Kawase I; Sugiyama H; Matsushima K
    Int Immunopharmacol; 2007 Jun; 7(6):845-57. PubMed ID: 17466918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activities of ginseng polysaccharide in C57BL/6 mice with Lewis lung carcinoma.
    Zhou X; Shi H; Jiang G; Zhou Y; Xu J
    Tumour Biol; 2014 Dec; 35(12):12561-6. PubMed ID: 25204674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
    Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
    J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of spontaneous metastatic lung cancer with tumor antigen-pulsed, interleukin-18 gene-modified dendritic cells].
    Chen J; Cao X; Xiu Q
    Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):779-82. PubMed ID: 11798964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal imprinting of vaccine-induced CD8⁺ T cells is crucial to inhibit the growth of mucosal tumors.
    Sandoval F; Terme M; Nizard M; Badoual C; Bureau MF; Freyburger L; Clement O; Marcheteau E; Gey A; Fraisse G; Bouguin C; Merillon N; Dransart E; Tran T; Quintin-Colonna F; Autret G; Thiebaud M; Suleman M; Riffault S; Wu TC; Launay O; Danel C; Taieb J; Richardson J; Zitvogel L; Fridman WH; Johannes L; Tartour E
    Sci Transl Med; 2013 Feb; 5(172):172ra20. PubMed ID: 23408053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal administration of CpG induces a rapid and transient cytokine response followed by dendritic and natural killer cell activation and recruitment in the mouse lung.
    Pesce I; Monaci E; Muzzi A; Tritto E; Tavarini S; Nuti S; De Gregorio E; Wack A
    J Innate Immun; 2010; 2(2):144-59. PubMed ID: 20375632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A VEGFR2-MICA bispecific antibody activates tumor-infiltrating lymphocytes and exhibits potent anti-tumor efficacy in mice.
    Xu Y; Zhang X; Wang Y; Pan M; Wang M; Zhang J
    Cancer Immunol Immunother; 2019 Sep; 68(9):1429-1441. PubMed ID: 31428800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of murine Lewis lung carcinoma metastases by combined chemotherapy and intranasal THF-gamma 2 immunotherapy.
    Rashid G; Ophir R; Pecht M; Lourie S; Meshorer A; Ben-Efraim S; Trainin N; Burstein Y; Keisari Y
    J Immunother Emphasis Tumor Immunol; 1996 Sep; 19(5):324-33. PubMed ID: 8941872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptotanshinone has curative dual anti-proliferative and immunotherapeutic effects on mouse Lewis lung carcinoma.
    Liu S; Han Z; Trivett AL; Lin H; Hannifin S; Yang D; Oppenheim JJ
    Cancer Immunol Immunother; 2019 Jul; 68(7):1059-1071. PubMed ID: 30972427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.